Scinai Immunotherapeutics (SCNI) Operating Leases (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Operating Leases for 2 consecutive years, with $2.0 million as the latest value for Q4 2025.

• Quarterly Operating Leases rose 39.87% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, up 39.87% year-over-year, with the annual reading at $2.0 million for FY2025, 39.87% up from the prior year.
• Operating Leases hit $2.0 million in Q4 2025 for Scinai Immunotherapeutics, up from $1.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.0 million in Q4 2025 to a low of $1.4 million in Q4 2024.

Peer Comparison